PRESS RELEASES More events are coming soon. Keyword Search Year: 20202019201820172016201520142013 02/07/20 Summary ToggleTRACON Pharmaceuticals Announces Change to Nasdaq Capital Market Printer Friendly PDF Version 12/20/19 Summary ToggleTRACON Pharmaceuticals, 3D Medicines and Jiangsu Alphamab Announce Partnership for Development of Subcutaneous PD-L1 Single-Domain Antibody in Soft Tissue Sarcoma Printer Friendly PDF Version 11/08/19 Summary ToggleTRACON Pharmaceuticals Announces Reverse Stock Split Printer Friendly PDF Version 11/05/19 Summary ToggleTRACON Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update Printer Friendly PDF Version 10/29/19 Summary ToggleTRACON to Report Third Quarter 2019 Company Highlights and Financial Results on November 5, 2019 Printer Friendly PDF Version 10/21/19 Summary ToggleTRACON Pharmaceuticals Announces $15 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC Printer Friendly PDF Version 10/07/19 Summary ToggleTRACON Pharmaceuticals Announces that Scientific Advisor William Kaelin, Jr., M.D. was Awarded the 2019 Nobel Prize in Physiology or Medicine Printer Friendly PDF Version 09/03/19 Summary ToggleTRACON Pharmaceuticals to Present at the Rodman & Renshaw 21st Annual Global Investment Conference Sponsored by H.C. Wainwright Printer Friendly PDF Version 08/29/19 Summary ToggleTRACON Pharmaceuticals to Present at the 2019 Wells Fargo Securities Healthcare Conference Printer Friendly PDF Version 08/28/19 Summary ToggleTRACON Pharmaceuticals to Present at the RHK Capital 4th annual Disruptive Growth Conference hosted by Reed Smith Printer Friendly PDF Version Pagination First page First Previous page Previous … Page 3 Current page 4 Page 5 Page 6 … Next page Next Last page Last
